UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000004641
Receipt number R000005536
Scientific Title Phase II clinical trial of peptide vaccination with HLA-A2402-restricted KIF20A and VEGFR1 epitope peptides with gemcitabine chemotherapy in patients with unresectable advanced pancreatic cancer
Date of disclosure of the study information 2010/12/01
Last modified on 2015/06/01 14:06:25

No. Disposal Last modified on Item of update
1 Insert 2010/12/01 00:11:15
2 Update 2012/03/06 20:13:33 Recruitment status
3 Update 2012/12/03 15:51:26 Post marketing survey by drug manufacture etc., specified by Japanese law.
4 Update 2015/06/01 14:01:11 TEL
Email
Last name of contact person
Last name of contact person
Address
Address
Email
5 Update 2015/06/01 14:06:25 Recruitment status